Over 50 lecturers from the top experts in the global biomed industry, who will join 80 Israeli lecturers, came to take part in the annual international event ILSI-Biodem Israel 2007, which opened yesterday
Delegations and representatives from 30 countries from abroad will take part this year in the international event ILSI-Biomed Israel 2007, which opened this morning, June 5, 2007, in Tel Aviv. The 'dry' figures are impressive: 120 exhibiting companies from Israel, which will be joined by 30 exhibiting companies from abroad. 80 lecturers from Israel and 50 lecturers from abroad will review in front of nearly 5000 participants the hottest and most talked about trends, innovations and developments in the life sciences industry today and it is estimated that the event will also be a suitable setting for the creation and closing of many deals.
The conference will be held this year in two parallel tracks - the "biomed" conference in the fields of medical devices, biotechnology and biopharma, and the annual international conference of the Stem Cell Association. The exhibition, which covers an area of 2,500 square meters, will feature a record number of companies - 150 - from the life sciences industry, from the fields of medical devices, biotechnology and biopharma.
"The Israeli life sciences industry has positioned itself in an impressive way," said Dr. Rafi Hoffstein, CEO of Hadassit and chairman of the 2007 ILSI-Biomed Israel Week. ”B, Europe and Asia. The broad spectrum that the organizing committee has created here, allows everyone involved in our industry to come, hear, voice, meet and exchange opinions. At the same time, it allows all the distinguished guests from abroad, and many of them are expected, to meet up close the entire life sciences industry in Israel in one high-quality event. Of course, a considerable amount of time will be devoted to a dialogue between the managers of venture capital funds and foreign investors and the companies, both from the field of biotechnology and from the field of medical devices."
According to Yael Rogel Fox, CEO of the Israel Life Sciences Industry Association, "The life sciences industry in Israel is succeeding in attracting a record number of participants from around the world, with their presence and commitment further validating the importance, professionalism and maturity of our industry. The entrepreneurship, innovation and creativity, which characterize the industry, prove Israel's position as a significant factor in the international market."
